As we age, our immune system doesn't just weaken; it actually locks itself into a harmful inflammatory state that makes serious infections like sepsis far more dangerous. Researchers at the University of Minnesota Medical School have identified the molecular culprit behind this self-sabotage, opening a potential pathway to protect older adults from life-threatening infections. What Happens to Immune Cells as We Age? The immune system's frontline defenders are cells called macrophages, which normally help fight infections and clear debris from the body. But as people grow older, something goes wrong. These aging macrophages become trapped in a chronic inflammatory state, releasing excessive amounts of inflammatory signaling molecules called cytokines that damage organs and worsen the body's response to severe infections. The research team, led by biochemistry graduate student In Hwa Jang, discovered the specific mechanism driving this problem. Aging macrophages produce a protein called GDF3 that sends signals back to the same cells that made it, creating a self-reinforcing loop of inflammation. This protein works through a pathway involving SMAD2/3, causing lasting changes to the cell's genetic material that lock it into an inflammatory state. How Could Blocking This Signal Help Older Adults? The research team tested whether interrupting this inflammatory loop could help. When they deleted the GDF3 gene in preclinical models, the harmful inflammatory response to bacterial toxins decreased significantly. More importantly, medications that blocked the GDF3-SMAD2/3 signaling pathway changed how inflammatory macrophages in fat tissue behaved and improved survival in older models exposed to severe infection. These findings suggest a new therapeutic target. Rather than trying to boost a weakened immune system in older adults, doctors might instead focus on preventing the immune system from overreacting in ways that damage the body. "Macrophages are critical to the development of inflammation; in our study, we identified a pathway which is used to maintain their inflammatory status. Our findings suggest that this pathway could be blocked to prevent the amplified inflammation that can be damaging to organ function and may be a promising target for future treatments that reduce harmful inflammation," explained Christina Camell, PhD, an associate professor with the University of Minnesota Medical School and College of Biological Sciences. Christina Camell, PhD, Associate Professor at University of Minnesota Medical School and College of Biological Sciences Ways to Understand the Real-World Impact of This Discovery - Sepsis Risk in Older Adults: Sepsis, a life-threatening condition where the body's response to infection causes tissue damage, is significantly more deadly in older adults. This research explains why their immune systems may overreact dangerously to bacterial infections. - GDF3 as a Biomarker: Through analysis of data from the Atherosclerosis Risk in Communities Study (ARIC), researchers found that GDF3 levels are linked to inflammatory signaling in older adults, suggesting it could become a measurable indicator of harmful inflammation risk. - Fat Tissue Connection: The inflammatory macrophages identified in this study reside in fat tissue, suggesting that body composition and metabolic health may play important roles in age-related inflammation and infection vulnerability. The study was published in Nature Aging in January 2026 and was supported by multiple grants from the National Institutes of Health, including funding specifically focused on the biology of aging. Dr. Camell recently received a 2025 AFAR (American Federation for Aging Research) Discovery Award to continue investigating how these inflammatory macrophages affect multiple metabolic organs and overall health during aging. The next phase of research will focus on identifying the precise molecular components involved in this pathway and clarifying how it controls specific inflammatory signals. For older adults and their families, this research offers hope that future treatments might not require boosting immunity, but rather fine-tuning it to prevent the dangerous overreactions that make infections like sepsis so deadly in later life. Understanding this self-sabotaging immune loop could eventually lead to therapies that help older bodies mount effective defenses without the collateral damage of runaway inflammation.
